Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimise-FLT3 in FLT3-mutated acute myeloid leukemia
ISRCTN34016918Phase 3Recruiting
- Sponsor
- Cardiff University
- Start
- Feb 2025
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
01
Overview
Phase 3 trial of midostaurin, gemtuzumab ozogamicin, daunorubicin, cytarabine, fludarabine and 2 more, sponsored by Cardiff University. Started Feb 2025; status: recruiting.
02
Drugs
midostauringemtuzumab ozogamicindaunorubicincytarabinefludarabine
Beyond the preview
Go deeper on ISRCTN34016918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN34016918.